Ischaemia and reperfusion contribute to the genesis of AF (atrial fibrillation). PVs (pulmonary veins) and the atria are important foci for AF initiation and maintenance. However, the effect of ischaemia and reperfusion on PVs and the atria has not yet been fully elucidated. In the present study, conventional microelectrodes were used to record the APs (action potentials) in isolated rabbit PV, LA (left atrium) and RA (right atrium) specimens during hypoxia and reoxygenation, and pharmacological interventions. Hypoxia reduced the PV beating rates from 1.8 + − 0.1 to 1.3 + − 0.2 and 0.8 + − 0.1 Hz at 30 and 60 min respectively (n = 8, P < 0.005), and induced EAD (early after depolarization) in three (37.5 %) of the PVs and DAD (delayed after depolarization) in one (12.5 %) of the PVs. Reoxygenation increased the PV spontaneous rate to 1.4 + − 0.2 Hz (P < 0.05) and induced PV burst firings (3.5 + − 0.1 Hz, P < 0.001) in six (75 %) of the PVs. Hypoxia shortened the AP duration in the LA and PVs, but not in the RA. Pretreatment with glibenclamide attenuated hypoxia-induced decreases in the PV spontaneous activity and the shortening of the LA and PV AP duration. Similar to those in hypoxia, the K ATP (ATP-sensitive potassium) channel opener pinacidil (30 μM) decreased PV spontaneous activity and shortened the AP duration. Pretreatment with 5 mM N-MPG [N-(mercaptopropionyl)glycine; a hydroxyl (
INTRODUCTION
AF (atrial fibrillation) is the most common sustained arrhythmia in clinical medicine and can cause cardiac dysfunction and stroke [1, 2] . Myocardial infarction and cardiothoracic surgery are frequent causes of acute AF [3] [4] [5] , which can be attributed to ischaemia and reperfusion with hypoxia and reoxygenation. The PVs (pulmonary veins) and LA (left atrium) are important AF initiators and substrates [6] [7] [8] [9] . PVs contain a mixture of pacemaker cells and working myocardium, and were suggested to be a subsidiary pacemaker for inducing atrial arrhythmias [10] . It is possible that hypoxia can directly alter PV arrhythmogenesis. Moreover, the K ATP (ATP-sensitive potassium) channel couples myocardial metabolism to membrane electrical activity, which may serve a cardioprotective function against various stresses, including ischaemia and hypoxia, through opening of the myocardial K ATP channel [11, 12] . When the intracellular ATP concentration decreases, as occurs during ischaemia and hypoxia, K ATP channels are activated, resulting in increased potassium conductance [13] , which may change PV and atrial electrical activities.
Injury of reoxygenation was suggested to be largely caused by ROS (reactive oxygen species). Oxidative stress can directly change cardiac electrophysiological characteristics and regulate calcium handling in cardiomyocytes [14] , which facilitates the genesis of AF. Our previous studies have also indicated the potential arrhythmogenesis of ROS in PVs and the LA [15] . Ischaemia and reperfusion play important roles in the genesis of AF and may involve a mechanism of oxidative stress as observed with hypoxia and reoxygenation. Moreover, HSPs (heat-shock proteins) were shown to attenuate ischaemia/reperfusion and decrease the occurrence of AF [16, 17] . Additionally, HSPs modulate PV and atrial electrical activities, which can contribute to their anti-AF activity [18, 19] . Therefore the purpose of the present study was to evaluate the electrophysiological effects of hypoxia and reoxygenation on PVs and the atria, and to investigate the role of the K ATP channel, oxidative stress and HSP70 in ischaemia/reperfusion-induced AF.
MATERIALS AND METHODS

Rabbit PV and atria tissue preparations
The investigation was approved by the local review board (JACUC-10-071), and conformed to the institutional Guide for the Care and Use of Laboratory Animals and the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health. As described previously [20, 21] , male New Zealand rabbits (weighing 1.5-2.0 kg) were anaesthetized with an intravenous injection of sodium pentobarbital (40 mg/kg of body weight), followed by an intravenous injection of heparin [1000 I.U. (international units)/kg of body weight]. A midline thoracotomy was then performed, and the heart and lungs were removed. For dissection of the PVs, the LA was opened by an incision along the mitral valve annulus extending from the coronary sinus to the septum in Tyrode's solution with a composition of 137 mM NaCl, 4 mM KCl, 15 mM NaHCO 3 , 0.5 mM NaH 2 PO 4 , 0.5 mM MgCl 2 , 2.7 mM CaCl 2 and 11 mM dextrose. The PVs were separated from the atrium at the level of the LA-PV junction and separated from the lungs at the ending of the PV myocardial sleeves. One end of the preparations, consisting of the PVs and atrial-PV junction, was pinned with needles to the bottom of a tissue bath. The other end (distal PV) was connected to a Grass FT03C force transducer with a silk thread. The adventitia or epicardial side of the preparations faced upwards. LA and RA (right atrium) tissues were prepared from the LA appendage (∼ 10 mm × 5 mm × 0.5 mm) and RA appendage (∼ 10 mm × 5 mm × 0.5 mm) respectively. The PV, LA and RA tissue strips were superfused at a constant rate (3 ml/min) with Tyrode's solution that was bubbled with 97 % O 2 /3 % CO 2 gas at 37
• C, and the preparations were allowed to equilibrate for 1 h before the electrophysiological study.
Electrophysiological and pharmacological studies
The transmembrane APs (action potentials) of the PVs, RA and LA were recorded using machine-pulled glass capillary microelectrodes filled with 3 M KCl. Preparations were connected to a WPI model FD223 electrometer under a tension of 150 mg. The electrical and mechanical events were simultaneously displayed on a Gould 4072 oscilloscope and Gould TA11 recorder. The signals were recorded digitally with a 16-bit accuracy at a rate of 125 kHz. An electrical stimulus with a 10-ms duration and supra-threshold strength was provided by a Grass S88 stimulator through a Grass SIU5B stimulus isolation unit. Hypoxic conditions were prepared by superfusion with normal Tyrode's solution bubbled with 95 % N 2 /5 % CO 2 . Reoxygenation conditions were prepared by superfusion with normal Tyrode's solution bubbled with 97 % O 2 /3 % CO 2 gas. The preparations were treated with hypoxic conditions for up to 60 min, followed by reoxygenation conditions for up to 60 min. For PVs with spontaneous activity, glibenclamide (100 μM), a K ATP channel blocker, was superfused alone or simultaneously with hypoxic conditions. Pinacidil (30 μM), a K ATP channel opener, was superfused alone. And 5 mM N-MPG [N-(mercaptopropionyl)glycine, an hydroxyl (
• OH) free-radical scavenger] or 300 μM chloramphenicol (a cytochrome P450 inhibitor that reduces ROS) was superfused before reoxygenation. Parameters of the AP were measured with 2-Hz electrical stimuli before and after drug administration in the LA, RA or PVs without spontaneous activity that was measured after 10 min of superfusion with 100 μM glibenclamide during hypoxia, followed by reoxygenation conditions.
The APA (AP amplitude) was obtained from the RMP (resting membrane potential) or maximum diastolic potential to the peak of AP depolarization. AP durations at a repolarization of 90 % of the APA were measured as the APD 90 . Spontaneous activity was defined as the constant occurrence of spontaneous APs in the absence of any electrical stimuli. Burst firing was defined as the occurrence of an accelerated spontaneous potential (higher than the basal rate) with sudden onset and termination. EADs (early after depolarizations) were defined as the interruption of the smooth contour of phase two or three of the AP. DADs (delayed after depolarizations) were defined as the presence of a spontaneous depolarization of the impulse after full repolarization had occurred. The EADs and DADs were selected from consistent deflections without abrupt changes of the RMP and AP morphology. Spontaneous activity was defined as a constant occurrence of spontaneous APs with no electrical stimuli. The SRI (stimulus to response interval) was defined as the time taken by capturing the preparations after the pacing spike was delivered [22] .
Detection of superoxide anions
PV tissue was placed in Hepes buffer solution with a composition of 13.8 g of NaCl, 9.52 g of Hepes, 0.72 g of KCl, 0.24 g of MgSO 4 ·7H 2 O, 0.528 g of CaCl 2 ·2H 2 O, 1.98 g of glucose, 4.2 g of NaHCO 3 and 0.28 g of KH 2 PO 4 in 2 litres of Q water bubbled with 95 % O 2 /5 % CO 2 at 37
• C for 10 min. Superoxide anion production was determined using a lucigenin-ECL (enhanced chemiluminescence) method. Each reaction well contained 100 μl of Hepes buffer solution, 50 μl of lucigenin (1.25 mM) and PV tissue in a 96-well microplate. Chemiluminometric measurements were performed using a microplate luminometer (Hidex). After detection, PV tissues were dried in a 37
• C oven for 2 weeks and weighed. Superoxide anions are expressed as c.p.s. (counts/s) of PV tissue minus c.p.s. of the blank divided by the dry weight of the PV tissue.
Western blot analysis of HSPs
As HSP70 plays an important role in cardiac electrophysiology and modulates the electrophysiological effects of hypoxia, we examined the expression of HSP70 in PV, LA and RA. PVs, RA and LA tissues were suspended in lysis buffer containing 50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1 % NP40 (Nonidet P40), 0.5 % sodium deoxycholate, 0.1 % SDS, 20 mM sodium fluoride, 2 mM sodium orthovanadate and protease inhibitor cocktails (Sigma-Aldrich). A Bradford assay was used to determine the protein concentration in homogenates and load equivalent amounts of total protein for each sample. Proteins were separated by SDS/PAGE (5 % or 8 % gels) under reducing conditions and electrophoretically transferred on to an equilibrated PVDF membrane (GE Healthcare). Blots were probed with primary antibodies against HSP70 (1:1000 dilution; MBL) overnight, and a secondary antibody conjugated to HRP (horseradish peroxidase) for 1 h. Bound antibodies were detected with an ECL detection system (Santa Cruz Biotechnology) and analysed with Image-Pro Plus software. Targeted bands were normalized to cardiac α-sarcomeric actin (Sigma-Aldrich) to confirm equal protein loading.
Statistical analysis
All continuous variables are expressed as means + − S.E.M. A repeated or non-repeated one-way ANOVA with Fisher's post-test was used to compare the differences among the PVs, RA and LA or the differences before and after hypoxia or reoxygenation. The effects of hypoxia in the absence or presence of glibenclamide or pinacidil, and the effects of reoxygenation in the presence or absence of chloramphenicol were compared by MannWhiteney rank sum test or unpaired Student's t test depending on the outcome of normality test. A χ 2 test was used to compare the arrhythmia incidence between the control and experimental groups. A P value < 0.05 was considered statistically significant.
RESULTS
Effects of hypoxia/reoxygenation on the electrical activity of the PVs and atria
In PVs with spontaneous activity (n = 8), hypoxia reduced the PV beating rates, whereas reoxygenation allowed the PV spontaneous rate to recover ( Figure 1A ). Hypoxia also induced the occurrences of EAD in three (37.5 %) of the PVs and the occurrence of DAD in one (12.5 %) PV ( Figure 1C) . Moreover, as in the example shown in Figure 1 (B), PV burst firings (3.5 + − 0.1 Hz) were found in six (75 %) of the PVs during reoxygenation, but not at the baseline or with hypoxia (P < 0.001).
In PVs without spontaneous activity (n = 7), hypoxia gradually shortened the APD 90 , and reduced the contractility, but did not change the APA or RMP (Figure 2 ). Reoxygenation partially reversed the hypoxiainduced shortening of the AP duration and decreases in contractility. Hypoxia decreased the PV conduction velocity with the prolongation of SRI, which was reversed after reoxygenation ( Figure 2 ).
Similar to that in PVs, hypoxia gradually shortened the APD 90 , reduced the contractility and prolonged SRI in LA (Figure 2) . Reoxygenation in the LA partially reversed the hypoxia-induced shortening of the AP duration, decreases of contractility and prolongation of SRI. In contrast, hypoxia and reoxygenation had no effect on the APD 90 , APA or RMP of the RA. Hypoxia reduced RA contractility, which was partially recovered after reoxygenation. Moreover, hypoxia prolonged SRI in RA and reoxygenation completely reversed it (Figure 2 ).
In addition, under hypoxia/reoxygenation conditions, the extent of APD 90 shortening was significantly greater in the LA than in the RA or PVs. However, the extent of decreasing contractility was smaller in the LA than in the RA and PVs (Figures 3A and 3B) . To study whether the different responses to hypoxia among PVs, the LA, and RA were caused by different expressions of HSPs, we found that the expression of HSP70 was higher in the RA than in the LA or PVs ( Figure 3C ).
Role of the K ATP channel in PVs during hypoxia
In order to study whether the K ATP channel plays a role in the effects of hypoxia on PVs, we administrated 100 μM glibenclamide in PVs before hypoxia and found that hypoxia in the presence of glibenclamide did not significantly reduce PV spontaneous activity at 30 min, and reduced the PV spontaneous activity to a lesser extent at 60 min compared with those without the presence of glibenclamide ( Figure 4A ). However, as in the examples in Figure 4 (B), in the presence of glibenclamide, hypoxia induced the occurrences of EAD (100 %), DAD (25 %) and PV burst firing. Moreover, as shown in 
ROS, N-MPG and chloramphenicol in PVs during hypoxia/reoxygenation
Moreover, as the examples show in Figure 7 (A), N-MPG (5 mM) further reduced PV spontaneous activity during hypoxia, and reoxygenation partially reversed the PV beating rates. However, different from that in hypoxia/reoxygenation without N-MPG (75 % compared with 13 %, n = 8, P < 0.05) ( Figure 7B) , reoxygenation in the presence of N-MPG did not induce an increased occurrence of PV burst firings.
In the presence of 300 μM chloramphenicol, hypoxia reduced the PV spontaneous activity, and reoxygenation reversed the spontaneous rate, which may have even returned to the baseline level (Figure 8 ). Moreover, similar to the findings in the presence of 5 mM N-MPG, 300 μM chloramphenicol significantly attenuated the occurrence of reoxygenation-induced PV burst firings, which was significantly less than that (18 % compared with 75 %, n = 11, P < 0.05) without chloramphenicol ( Figure 8C ). The superoxide (O 2
• − ) significantly increased during hypoxia/reoxygenation, which was significantly lower in chloramphenicol-treated PVs with spontaneous activity. Moreover, ROS were reduced by chloramphenicol, a finding that is in parallel with the incidence of burst firings and the change in spontaneous activity in PVs with spontaneous activity.
DISCUSSION
In the present study, we found that hypoxia reduced the PV beating rates and shortened the AP duration in the LA and PVs, but not in the RA. Reoxygenation reversed the hypoxic effects, but induced PV burst firings. These effects could be modulated by glibenclamide, and attenuated by free-radical scavenger or CYP (cytochrome P450) inhibitor. In addition, HSP70 was differentially expressed in RA, LA and PVs.
Hypoxia was shown to significantly change cardiac electrophysiology [23] [24] [25] . Hypoxia can decrease the rate of spontaneous impulse initiation in sinoatrial nodal fibres by decreasing the slope of diastolic depolarization [26] . Similarly, the present study also found that hypoxia can decrease the PV spontaneous activity. It was shown that activation of the K ATP channel underlies the decreasing pacemaker activity. The present study found that the administration of a K ATP channel blocker (glibenclamide) can attenuate the AP duration shortening in response to hypoxic effects on PVs, which suggests that the activation of the K ATP channel may be the underlying mechanism. Similar effects of hypoxia and a K ATP channel opener (pinacidil) on reducing PV spontaneous activity also suggest a role of the K ATP channel in PV electrophysiology. Hypoxia also induced the occurrences of EADs and DADs in PVs with spontaneous activity, which was enhanced in the presence of glibenclamide. A study with a canine model showed that hypoxia is associated with the development of triggered activity, which may be attributed to the attenuated ATP-dependent uptake and release of Ca 2 + from the SR (sarcoplasmic reticulum) [14] . Therefore hypoxia may induce both DADs and triggered activity in PVs. K ATP channel activation during ischaemia postpones the onset of irreversible damage and reduces the size of the area of myocardial infarction [12] . Blockade of K ATP channels by sulfonylurea derivatives abolishes these cardioprotective effects. Cells in the ischaemic area depolarize within minutes, at least partly due to alterations in extracellular potassium concentrations, and secondary to depolarization, the conduction velocity decreases [13] . Moreover, attenuated shortening of the AP duration by a K ATP channel blocker may facilitate greater calcium influx during hypoxia, which will produce more triggered activity with the genesis of burst firings [27] . However, it is not clear whether the non-physiological hypoxic conditions can change cell viability and induce apotosis or necrosis.
A previous study also indicated that ischaemia progressively shortens the AP duration caused by opening of K ATP channels [27] . In the present study, hypoxia significantly shortened the AP duration and reduced conduction velocity measured from SRI in PVs, LA and RA, which is similar to the known effect of ischaemia on atrial conduction [28] . The administration of glibenclamide attenuated the hypoxiainduced shortening of the AP duration, which also suggests a role of K ATP channels in hypoxia. However, for the first time, the present study found that hypoxia may differentially change the cardiac electrophysiology between the RA and LA. The dissimilar effects of hypoxia on AP shortening between the RA and LA will increase dispersions of the AP duration to facilitate the maintenance of AF. Although the mechanism for the different effects of hypoxia on the RA and LA is not clear, it is possible that higher expression of HSP70 in the RA may play a role at least in part in the different responses to oxidative stress between the RA and LA. HSP70 is known to be a protective chaperone molecule that is synthesized in response to ischaemia and stress agents [29] . The higher expression of HSP70 in the RA may be caused by the effects of low-oxygenated blood in the RA, and provide protective effects on hypoxia as shown by unchanged AP duration. HSP70 has been shown to promote K ATP function [30] and provide cardioprotective effects in ischaemia [31] . HSP70 may increase transient outward and rapidly activating delayed-rectifier potassium currents [32, 18] . Moreover, HSP70 can protect the heart against AF [16] . Low preoperative HSP70 atrial myocardial levels correlate significantly with a high incidence of postoperative AF after cardiac surgery [33] . These findings suggest that HSP70 may attenuate the occurrences of AF. Therefore the lower expressions of HSP70 in PVs or LA may play a role in their high arrhythmogenesis [18] .
Reperfusion arrhythmias, including postoperative AFs, are an important and common complication associated with CABGs (coronary artery bypass grafts) and other surgical conditions with ischaemia and subsequent reperfusion such as angioplasty and thrombolytic therapy [34] . Overproduction of oxygenderived free radicals with intracellular calcium overload was proposed to be the underling mechanism [14, 35] . In the present study, reoxygenation not only reversed the hypoxic effects on decreasing PV electrical activity but also induced the occurrences of triggered activity (EAD and DAD) and burst firings. The similarity between the electrophysiological characteristics of PV burst firing and those in clinical focal AFs or atrial tachycardia strongly suggest that reoxygenation has a direct arrhythmogenic effect on PVs. This finding is consistent with our previous study which showed that oxidative stress induced by H 2 O 2 can increase PV arrhythmogenesis with the occurrence of PV burst firing and EADs [15] . Measurement of the superoxide anion also found higher ROS during reoxygenation. Moreover, N-MPG can attenuate reoxygenation-induced PV arrhythmogenesis, which also suggests the potential role of ROS in PV arrhythmogenesis. ROS overproduction is associated with reduced oxygen consumption, reflecting electron transport dysfunction caused by the preceding hypoxia that is severe enough to cause partial respiratory inhibition [36] . Cardiac CYPs play a role in ROS production during reoxygenation [37, 38] . Therefore chloramphenicol can reduce ROS production through inhibiting the activity of CYPs. In the present study, we found that chloramphenicol not only reduced ROS but also attenuated the arrhythmogenic effects Examples (A) and average data (B) of spontaneous activity during hypoxia and hypoxia/reoxygenation with 300 μM chloramphenicol on PVs with spontaneous activity. (C) Average data of burst firing incidence, spontaneous activity change and ROS production under reoxygenation before and after 300 μM chloramphenicol in PVs with spontaneous activity.
of reoxygenation, which suggests that CYPs may play an important role in PV arrhythmogenesis under ischaemia/reperfusion or hypoxia/reoxygenation.
In conclusions, hypoxia/reoxygenation significantly increases PV arrhythmogenesis and induces different electrophysiological responses in rabbit RA and LA. These effects may be through activation of K ATP channels during hypoxia and generation of ROS during reoxygenation, which may play an important role in the mechanism of ischaemia/reperfusion-induced AF.
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